Your browser doesn't support javascript.
loading
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms].
Bao, M; Shi, D Y; Shi, H X; Liu, X L; Duan, M H; Zhuang, J L; Du, X; Qin, L; Hui, W H; Liang, R; Wang, M F; Chen, Y; Li, D Y; Yang, W; Tang, G S; Zhang, W H; Kuang, X; Su, W; Han, Y Q; Chen, L M; Xu, J H; Liu, Z G; Huang, J; Zhao, C T; Tong, H Y; Hu, J D; Chen, C Y; Chen, X Q; Xiao, Z J; Jiang, Q.
Afiliación
  • Bao M; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Shi DY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Shi HX; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
  • Liu XL; Nanfang Hospital, Southern Medical University, Guangzhou 510080, China.
  • Duan MH; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Zhuang JL; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
  • Du X; The Second People's Hospital of Shenzhen, Shenzhen 518035, China.
  • Qin L; The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Zhengzhou 471003, China.
  • Hui WH; Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
  • Liang R; Xi Jing Hospital, The Fourth Military Medical University, Xi An 710032, China.
  • Wang MF; Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
  • Chen Y; Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
  • Li DY; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
  • Yang W; Shengjing Hospital Affiliated to China Medical University, Shenyang 110020, China.
  • Tang GS; Department of Hematology, Institute of Hematology, The First Affiliated Hospital of Naval Medical University, Changhai Hospital, Shanghai 200433, China.
  • Zhang WH; Department of Hematology, First Hospital of Shanxi Medical University, Taiyuan 300012, China.
  • Kuang X; Kaifeng Central Hospital, Kaifeng 475000, China.
  • Su W; Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China.
  • Han YQ; The Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China.
  • Chen LM; The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Xu JH; Department of Hematology, Qiqihar First Hospital, Qiqihar 161005, China.
  • Liu ZG; Shengjing Hospital Affiliated to China Medical University, Shenyang 110020, China.
  • Huang J; Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 322000, China.
  • Zhao CT; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.
  • Tong HY; Department of Hematology, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou 310003, China.
  • Hu JD; Department of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
  • Chen CY; Department of Hematology, Shandong University Qilu Hospital, Jinan 250012, China.
  • Chen XQ; Institute of Hematology & Affiliated Hospital, Medicine School, Northwestern University, Xi'an 710069, China.
  • Xiao ZJ; Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, National Clinical Research Center for Blood Diseases, The State Key Laboratory of Experimental Hematology, Tianjin 300020, China.
  • Jiang Q; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing 100044, China.
Zhonghua Xue Ye Xue Za Zhi ; 42(12): 985-992, 2021 Dec 14.
Article en Zh | MEDLINE | ID: mdl-35045668

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_cobertura_universal / 3_diarrhea Asunto principal: Policitemia Vera / Trastornos Mieloproliferativos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_cobertura_universal / 3_diarrhea Asunto principal: Policitemia Vera / Trastornos Mieloproliferativos Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Año: 2021 Tipo del documento: Article País de afiliación: China
...